Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites
- PMID: 629360
- DOI: 10.1152/ajpheart.1978.234.3.H235
Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites
Abstract
To examine the disposition of [3H]norepinephrine ([3H]NE) in adrenergically innervated veins, helical strips of canine saphenous veins were incubated in Krebs-Ringer solution containing D,L[3H]NE (2 X 10(-7) M) for 2 h. [3H]NE and its metabolites were measured in extracts of veins and in superfusate (Krebs-Ringer) collected during basal conditions and during release of [3H]NE evoked by electrical stimulation (1-8 Hz), tyramine (5 X 10(-6) to 5 X 10(-4) M), or high concentrations of potassium (35-100 meq/liter). During basal conditions, the efflux from veins comprised mainly metabolits of [3H]NE, especially 3,4-dihydroxphenylglycol (DOPEG) and 3-methoxy-4-hydroxyphenylglycol (MOPEG); this pattern was unchanged by cocaine treatment, and monoamine oxidase inhibition reduced the formation of DOPEG. During evoked release of NE, the major metabolites in the perfusate were DOPEG, MOPEG, and normetanephrine, and their proportions differed with the stimulus used: O-methylated metabolites in the perfusate always increased more than did the deaminated catechol compounds; DOPEG and MOPEG were released in greater amounts than the corresponding acids; and cocaine treatment caused a higher content of all metabolites except DOPEG. 3-Methoxy-4-hydroxymandelic acid was also formed by the vein but was retained in the tissue.
Similar articles
-
Deamination of released 3H-noradrenaline in the canine saphenous vein.Naunyn Schmiedebergs Arch Pharmacol. 1982 Feb;318(3):148-57. doi: 10.1007/BF00500474. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 7063044
-
Effects of S-11701 on accumulation, release and metabolism of norepinephrine in isolated canine saphenous veins.Gen Pharmacol. 1992 Nov;23(6):1079-85. doi: 10.1016/0306-3623(92)90290-z. Gen Pharmacol. 1992. PMID: 1487118
-
Effect of moderate cooling on adrenergic neuroeffector interaction in canine cutaneous veins.Blood Vessels. 1981;18(6):281-95. doi: 10.1159/000158361. Blood Vessels. 1981. PMID: 7326437
-
Dihydroxyphenylglycol as an index of neuronal uptake in dog saphenous vein.Am J Physiol. 1989 Dec;257(6 Pt 2):H1945-51. doi: 10.1152/ajpheart.1989.257.6.H1945. Am J Physiol. 1989. PMID: 2603979
-
Origin and distribution of 3-methoxy-4-hydroxyphenylglycol in body fluids.Biochem Pharmacol. 1979 Oct 15;28(20):3043-50. doi: 10.1016/0006-2952(79)90611-7. Biochem Pharmacol. 1979. PMID: 391236 Review. No abstract available.
Cited by
-
Metabolism of endogenous and exogenous noradrenaline in the rabbit perfused heart.Naunyn Schmiedebergs Arch Pharmacol. 1982 May;319(2):125-9. doi: 10.1007/BF00503924. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 7110374
-
Cocaine and neuronal uptake in the canine saphenous vein.Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(3):207-12. doi: 10.1007/BF00505487. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 7155201 No abstract available.
-
Modulation of the concentration of noradrenaline at the neuro-effector junction in human saphenous vein.Br J Pharmacol. 1983 Jun;79(2):577-85. doi: 10.1111/j.1476-5381.1983.tb11032.x. Br J Pharmacol. 1983. PMID: 6317115 Free PMC article.
-
Deamination of released 3H-noradrenaline in the canine saphenous vein.Naunyn Schmiedebergs Arch Pharmacol. 1982 Feb;318(3):148-57. doi: 10.1007/BF00500474. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 7063044
-
The effect of labetalol on the release of [3H]-labelled noradrenaline and its metabolites from dog isolated saphenous vein [proceedings].Br J Pharmacol. 1979 May;66(1):151P. Br J Pharmacol. 1979. PMID: 454943 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources